New insights into IGF-1 signaling in the heart

Trends Endocrinol Metab. 2014 Mar;25(3):128-37. doi: 10.1016/j.tem.2013.12.002. Epub 2013 Dec 28.

Abstract

Insulin-like growth factor 1 (IGF-1) signaling regulates contractility, metabolism, hypertrophy, autophagy, senescence, and apoptosis in the heart. IGF-1 deficiency is associated with an increased risk of cardiovascular disease, whereas cardiac activation of IGF-1 receptor (IGF-1R) protects from the detrimental effects of a high-fat diet and myocardial infarction. IGF-1R activates multiple pathways through its intrinsic tyrosine kinase activity and through coupling to heterotrimeric G protein. These pathways involve classic second messengers, phosphorylation cascades, lipid signaling, Ca(2+) transients, and gene expression. In addition, IGF-1R triggers signaling in different subcellular locations including the plasma membrane, perinuclear T tubules, and also in internalized vesicles. In this review, we provide a fresh and updated view of the complex IGF-1 scenario in the heart, including a critical focus on therapeutic strategies.

Keywords: IGF-1R; calcium; cardiac progenitor stem cells; inter-organelle communication.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Calcium / metabolism
  • Humans
  • Myocardial Infarction / metabolism
  • Myocardium / metabolism
  • Phosphorylation
  • Receptor, IGF Type 1 / metabolism*
  • Signal Transduction / physiology
  • Stem Cells / cytology

Substances

  • Receptor, IGF Type 1
  • Calcium